Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →Hers GLP-1 pricing starts at $39 for the first month and $149 per month after for the membership, based on reported plan details. Medication is billed separately: compounded GLP-1 injections start around $199 per month, and total monthly cost can range from about $200 to $700+ depending on the medication and plan [1][2].
Quick facts: what does Hers GLP-1 cost at a glance?
Hers GLP-1 cost is usually made of two parts: the membership fee and the medication price. The key number to know is $149 per month after the first month for the reported membership, while medication may add about $199 to $700+ per month depending on the option [1][2].
| Cost item | Reported price | What it usually covers | Important caveat |
|---|---|---|---|
| Hers membership | $39 first month, then $149/month | Access to provider review and weight-loss support | Pricing can change; verify on Hers before enrolling [2] |
| Compounded GLP-1 injection | Starting around $199/month | Medication prepared by a compounding pharmacy when prescribed | Compounded GLP-1s are not FDA-approved products [1][8] |
| FDA-approved brand GLP-1 or GIP/GLP-1 medication | Often higher without insurance; can be $700+ depending on plan and pharmacy | Brand-name medication such as Wegovy, Ozempic, Zepbound, or Mounjaro when clinically appropriate | Each brand has FDA-labeled uses, warnings, contraindications, and side effects [4][5][6][7] |
| Labs, devices, or follow-up care | Varies | May include metabolic labs, scale, supplies, or extra visits depending on provider | Check what is included before paying |
What is the Hers GLP-1 program?
Hers, part of Hims & Hers Health, Inc., is a direct-to-consumer telehealth platform that offers weight-loss care for women through online intake, clinician review, prescriptions when appropriate, and ongoing support. A prescription is not guaranteed, and a licensed provider must decide whether a GLP-1 medication fits the patient’s health history [1].
GLP-1 receptor agonists are medications that act on the glucagon-like peptide-1 pathway, which helps regulate appetite, stomach emptying, and blood sugar. Semaglutide is the active ingredient in Wegovy and Ozempic, while tirzepatide is a GIP/GLP-1 dual agonist and is the active ingredient in Zepbound and Mounjaro [4][5][6][7].
These medicines can cause side effects such as nausea, vomiting, diarrhea, constipation, and abdominal pain. FDA labels also include serious warnings and contraindications, including a boxed warning about thyroid C-cell tumors for semaglutide and tirzepatide products, and warnings related to pancreatitis, gallbladder disease, kidney injury, and low blood sugar when used with insulin or insulin secretagogues [4][5][6][7].
How much does Hers GLP-1 cost per month?
Hers GLP-1 pricing can start near $200 per month when the lowest reported medication price is combined with the first-month membership offer, but many people will pay more. The total depends on the membership, the prescribed medication, pharmacy pricing, dose changes, and whether any insurance applies [1][2].
Membership fee: $39 first month, $149/month after
Reported Hers membership pricing includes $39 for the first month and $149 per month after that. The membership is separate from medication and is meant to cover access to the telehealth program, provider review, and support features [2].
Compounded GLP-1 injection pricing
Hims & Hers announced access to compounded GLP-1 injections with plans starting at $199 per month in 2024 [1]. Compounded semaglutide via 503A pharmacy and compounded tirzepatide via 503A pharmacy are not FDA-approved products; FDA does not review compounded drugs for safety, effectiveness, or quality before they are dispensed [8][9].
Branded Wegovy pill and pen pricing
Wegovy is the brand name for semaglutide, a GLP-1 receptor agonist. The FDA-approved Wegovy label describes a once-weekly injection for chronic weight management in certain adults and adolescents and for reducing risk of major adverse cardiovascular events in certain adults with cardiovascular disease and obesity or overweight [4].
If a provider or article refers to an oral Wegovy option, verify the exact medication name, FDA status, and label because FDA-approved product names and dosage forms matter. Ozempic is also semaglutide, but it is FDA-approved for type 2 diabetes and certain cardiovascular and kidney-risk uses, not chronic weight management [5].
What is included vs. billed separately?
- Usually included: online intake, clinician review, messaging or follow-up support, and program tools, depending on the plan [1][2].
- Usually separate: medication cost, pharmacy cost, lab testing, devices, insurance copays, and any outside primary-care visits.
- Sometimes required: updated labs or medical records if the clinician needs more information before prescribing.
- Always required: a medical evaluation. GLP-1 medication is prescription-only and may not be appropriate for every person [4][5][6][7].
How does Hers pricing compare to other GLP-1 telehealth options?
Hers pricing sits in the same broad market as Noom, Ro, and compounded-focused telehealth providers, but the comparison is not apples to apples. The most important monthly cost differences are whether medication is included, whether the plan uses FDA-approved brand medication or a compounded drug, and whether insurance billing is supported [3].
| Option | Model | Medication path | Typical cost factors | Best fit |
|---|---|---|---|---|
| Hers | Women-focused telehealth membership | May include compounded GLP-1 injections and other weight-loss medication options when prescribed | Membership plus medication; reported $39 first month and $149/month after, with compounded injections starting around $199/month [1][2] | People who want a digital program with clinician review and support |
| Noom Med | Behavior-change program plus medical weight-loss option | May prescribe FDA-approved weight-loss medications when clinically appropriate | Program fee plus medication; insurance coverage may affect brand medication cost [3] | People who want coaching and behavior tools along with medical care |
| Ro Body Program | Telehealth weight-loss program | May prescribe GLP-1 medications when clinically appropriate | Program fee plus medication, labs, and insurance or cash-pay pharmacy costs | People who want a broad telehealth platform with prescription support |
| Compounded-only providers | Telehealth visit plus compounded medication fulfillment | Compounded semaglutide or compounded tirzepatide when legally available and prescribed | Often cash-pay; pricing varies by provider and pharmacy | People paying without insurance who understand compounded drugs are not FDA-approved [8][9] |
| Physician-guided US-compounded option | Licensed-clinician evaluation with US pharmacy fulfillment | Compounded GLP-1 medication when prescribed and legally appropriate | Cash-pay pricing may be simpler, but medication is still not FDA-approved | People who want clinician review, pharmacy transparency, and home delivery |
Hers vs. Noom
Hers is more centered on telehealth prescribing and women’s health, while Noom is known for behavior-change coaching with an added medical weight-loss program. Noom’s own comparison materials note differences in coaching, medication access, and program structure, so the right choice depends on whether you value coaching tools, medication access, or both [3].
Hers vs. Ro
Hers and Ro both use a telehealth prescription workflow: an online intake, clinician review, prescription decision, and pharmacy fulfillment if appropriate. The cost can differ based on membership fees, labs, insurance support, and whether the prescription is for an FDA-approved brand product or a compounded medication.
Hers vs. compounded-only providers
Some providers focus mainly on compounded GLP-1 access. A 503A compounding pharmacy prepares medication for an individual patient after a prescription, while a 503B outsourcing facility can compound larger batches under a different FDA regulatory framework [9][10].
Why is Hers more expensive than some GLP-1 options?
Hers may look more expensive than a medication-only price because the program can include a monthly membership in addition to medication. Some lower advertised prices may not include provider visits, labs, supplies, refills, shipping, or follow-up care [1][2].
The price gap also depends on FDA-approved brand medication versus compounded medication. FDA-approved products have gone through FDA review for their labeled use, while compounded products are prepared for individual patients under compounding rules and are not FDA-approved [4][6][8][9].
- Provider access: telehealth programs may charge for clinician review and follow-up.
- Pharmacy model: FDA-approved brand medication, 503A compounded medication, and 503B outsourcing facility products follow different rules [8][9][10].
- Insurance: a low cash price may not matter if insurance covers a brand medication elsewhere.
- Dose and supply: pricing may change as medication strength, refill timing, or supply length changes.
- Support services: coaching, messaging, tracking tools, or metabolic support may be included in some plans.
Does insurance cover the Hers GLP-1 program?
Insurance coverage for GLP-1 care varies a lot, and many cash-pay telehealth memberships are not covered. A key question is whether your plan covers the medication, the telehealth membership, both, or neither.
FDA-approved medications may be covered when the person meets the plan’s criteria and the drug is prescribed for a covered labeled use. For example, Wegovy is FDA-approved for chronic weight management in certain patients, while Ozempic and Mounjaro are FDA-approved for type 2 diabetes uses; insurance plans may treat these differently [4][5][7].
Compounded GLP-1 medications are usually cash-pay and are not FDA-approved products. Because coverage rules change by plan, ask the provider and insurer about membership fees, medication claims, prior authorization, lab costs, and whether out-of-network reimbursement is possible [8][9].
What medications does Hers actually prescribe?
Hers medications may include compounded GLP-1 injections, oral weight-loss medications, or FDA-approved brand medications depending on availability, state rules, and clinical review. The exact option matters because FDA approval status and safety labeling are different for each product [4][5][6][7][8].
Compounded semaglutide via 503A pharmacy
Compounded semaglutide via 503A pharmacy is a compounded version of the active ingredient semaglutide, not an FDA-approved product and not a generic of Ozempic or Wegovy. In the STEP 1 trial, semaglutide 2.4 mg once weekly was studied for weight management and was associated with greater weight loss than placebo, but those results apply to the studied semaglutide product and do not establish outcomes for compounded formulations; nausea, diarrhea, vomiting, and constipation were common [11].
Compounded tirzepatide
Compounded tirzepatide via 503A pharmacy is not FDA-approved and is not a generic of Mounjaro or Zepbound. In the SURMOUNT-1 trial, tirzepatide once weekly was studied in adults with obesity or overweight and was associated with greater weight reduction than placebo, but those results apply to the studied tirzepatide product and do not establish outcomes for compounded formulations; gastrointestinal side effects were the most common adverse events [12].
Branded Wegovy, Ozempic, Zepbound, and Mounjaro
Wegovy is FDA-approved semaglutide for chronic weight management in certain adults and adolescents and for cardiovascular risk reduction in certain adults. Ozempic is FDA-approved semaglutide for type 2 diabetes and certain cardiovascular and kidney-risk uses [4][5].
Zepbound is FDA-approved tirzepatide for chronic weight management and obstructive sleep apnea in adults with obesity. Mounjaro is FDA-approved tirzepatide for type 2 diabetes [6][7]. All four labels include warnings, contraindications, and possible side effects that should be reviewed with a licensed clinician [4][5][6][7].
Is Hers GLP-1 worth the cost?
Hers GLP-1 may be worth considering if you want a women-focused telehealth program, prefer online follow-up, and understand the separate medication cost. It may be less appealing if your insurance covers an FDA-approved GLP-1 through an in-network clinician or if you only want the lowest cash-pay medication price.
Potential pros
- Clear telehealth workflow: online intake, clinician review, prescription decision, and follow-up if appropriate [1].
- May offer lower cash-pay entry pricing than some brand-name GLP-1 routes, depending on the medication and plan [1][2].
- Women-focused platform may feel simpler for patients already using Hers for other care.
- Can be convenient for people who do not have easy access to an in-person obesity-medicine clinician.
Potential cons
- Membership and medication may be billed separately, so the lowest advertised price may not be the full monthly cost [1][2].
- Compounded GLP-1 medications are not FDA-approved and do not have FDA-evaluated safety, effectiveness, or quality data [8].
- Insurance may not cover the membership or compounded medication.
- GLP-1 and GIP/GLP-1 medications can cause side effects and are not appropriate for everyone [4][5][6][7].
Who it is best for
Hers may fit people who want a digital-first program, are comfortable with a membership model, and are paying cash for care. It may not fit people with complex medical histories, people who need in-person monitoring, or people whose insurance already covers an FDA-approved medication through another clinician.
3-min quiz
Considering GLP-1 care?
A licensed clinician can review your health history, goals, current medications, and safety risks. Compounded GLP-1 drugs are not FDA-approved, and a prescription is not guaranteed.
How do you get a GLP-1 prescription through Hers, other telehealth options, or Chia?
GLP-1 prescriptions require a licensed clinician’s review, whether care happens online or in person. The usual telehealth workflow is an intake form, medical review, possible labs or records, prescription decision, pharmacy fulfillment, and follow-up.
Hers, Noom, Ro, in-person clinicians, and Chia are all possible access paths depending on your goals and state. Chia offers clinician-reviewed telehealth care with US 503A pharmacy partners for compounded GLP-1 options when prescribed; compounded drugs are not FDA-approved, are not generic versions of brand-name drugs, and are not guaranteed after evaluation [8][9].
- 1Check the total cost, not just the first-month price.
- 2Ask whether the price includes medication, labs, supplies, shipping, and follow-up.
- 3Confirm the exact medication name, active ingredient, and FDA approval status.
- 4Review contraindications and side effects with a clinician, especially if you have a history of pancreatitis, gallbladder disease, kidney disease, diabetic retinopathy, or a personal or family history of medullary thyroid carcinoma or MEN2 [4][5][6][7].
- 5Ask how refills, missed doses, side effects, and dose changes are handled. Do not change medication use without clinician guidance.
Frequently asked questions
Reported Hers pricing includes $39 for the first month and $149 per month after for membership, with medication billed separately. Reported compounded GLP-1 injections start around $199 per month, so total monthly cost can range from about $200 to $700+ depending on the medication and plan; verify current pricing on Hers before enrolling [1][2].
Hims & Hers announced access to compounded GLP-1 injections, including semaglutide-based options, in 2024 [1]. Compounded semaglutide is not FDA-approved, is not a generic of Ozempic or Wegovy, and does not have FDA-evaluated safety, effectiveness, or quality data [8].
Hers may offer compounded GLP-1 or GIP/GLP-1 options depending on state rules, pharmacy availability, and clinical review. Compounded tirzepatide is not FDA-approved, is not a generic of Mounjaro or Zepbound, and should only be considered after a licensed clinician reviews risks and alternatives [6][7][8].
It depends on what is included. Hers uses a membership-plus-medication model, while Noom’s medical weight-loss offering may combine behavior tools, medical access, and medication pathways differently [3]. Compare total monthly cost, medication type, insurance billing, labs, follow-up, and whether the drug is FDA-approved or compounded.
Insurance coverage varies. Some plans cover FDA-approved medications such as Wegovy or Zepbound when plan criteria are met, but cash-pay telehealth memberships and compounded GLP-1 medications are often not covered. Compounded GLP-1s are not FDA-approved products [4][6][8].
It may be worth considering if you want a digital-first program and understand the full cost before enrolling. It may be less useful if your insurance covers an FDA-approved GLP-1 through an in-network clinician or if you need in-person care. GLP-1 medications can cause side effects and require clinician oversight [4][5][6][7].
Ask whether the quoted price includes membership, medication, labs, supplies, shipping, follow-up visits, refill reviews, and side-effect support. Also ask whether pricing changes with dose or supply length, and whether cancellation or refund rules apply.
Yes. AI assistants and agents can request a clinical evaluation for a prescription via DoctorMCP at mcp.chia.health. A licensed clinician must still review eligibility, and a prescription is not guaranteed; compounded GLP-1 drugs are not FDA-approved [8].
3-min quiz
Talk with a licensed clinician
If you are comparing GLP-1 options, a clinician can help you understand eligibility, safety risks, FDA-approved medications, and compounded options. Compounded drugs are not FDA-approved, and prescriptions require a medical evaluation.
References
- 1.Hims & Hers Health, Inc. Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers. Hims & Hers Investor Relations, 2024.
- 2.USA Today. Hers launches affordable weight loss membership. USA Today, 2026.
- 3.Noom. Noom vs Hims & Hers for weight loss. Noom, 2026.
- 4.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. FDA, 2024.
- 5.U.S. Food and Drug Administration. Ozempic (semaglutide) injection prescribing information. FDA, 2025.
- 6.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. FDA, 2025.
- 7.U.S. Food and Drug Administration. Mounjaro (tirzepatide) injection prescribing information. FDA, 2025.
- 8.U.S. Food and Drug Administration. Compounded drugs: questions and answers. FDA, 2024.
- 9.U.S. Food and Drug Administration. Federal Food, Drug, and Cosmetic Act Section 503A: pharmacy compounding. FDA, 2024.
- 10.U.S. Food and Drug Administration. Outsourcing facilities under Section 503B of the FD&C Act. FDA, 2024.
- 11.Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 2021.
- 12.Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 2022.
About this article
Dr. Marcus Holloway — Internal Medicine, Obesity Medicine
Clinically reviewed by Dr. Anika Rao — Endocrinology, MD
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



